The association between CNTD2 expression and a more aggressive phenotype was further corroborated by the results obtained in vivo (Fig. 5), as well as by the dramatic correlation between high levels of CNTD2 and a decreased overall survival of a large set of lung cancer patients (Fig. 6). The gene discussed is CCNP; the disease is lung cancer.